The INTER-EWING-1 trial is in development and will open at the end of 2022.
The CI for the INTER-EWING-1 trial is Professor Bernadette Brennan, University of Manchester (UK). The trial will be sponsored by University of Birmingham (UK) through the Cancer Research UK Clinical Trials Unit (CRCTU).
A summary of the trial is available here.
Cancer Research UK are funders of INTER-EWING-1 and patients will be recruited from multiple countries.
Surgical guidelines will be made available later in 2022.